Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6775790

N=C1CCCN1c1ccc(C(=O)NCCOc2ccc3ccnc(N)c3c2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
F10 P00742 8/20 0.41
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
LMNA P02545 1/20 0.36
ALDH1A1 P00352 1/20 0.35
KLKB1 P03952 1/20 0.35
POLB P06746 2/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 2/20 0.35
MAPT P10636 1/20 0.35
RECQL P46063 1/20 0.35
F2 P00734 1/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
TRPV1 Q8NER1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6765882 0.84 F10 (0.56) F10ALDH1A1KLKB1NPC1F2
Trifluoroacetic Acid SCHEMBL6769455 0.82 F10 (0.45) F10NPC1
Trifluoroacetic Acid SCHEMBL6769129 0.82 F10 (0.53) F10ALDH1A1KLKB1F2
Trifluoroacetic Acid SCHEMBL6890249 0.81 F10 (0.49) F10KLKB1POLBNPC1RAB9A
Trifluoroacetic Acid SCHEMBL6775993 0.81 F10 (0.42) F10ALDH1A1KLKB1POLBNPC1
Trifluoroacetic Acid SCHEMBL6770182 0.80 NPC1 (0.42) F10ALDH1A1KLKB1POLBNPC1
Trifluoroacetic Acid SCHEMBL6770318 0.79 TRPV1 (0.42) F10LMNAKLKB1NPC1RAB9A
Trifluoroacetic Acid SCHEMBL6770954 0.79 F10 (0.63) F10RAB9AMAPTF2
Trifluoroacetic Acid SCHEMBL6775232 0.77 RAD52 (0.42) F10ALDH1A1KLKB1POLBNPC1
Trifluoroacetic Acid SCHEMBL6771145 0.77 ROCK1 (0.48) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825181-B1 ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X AJINOMOTO CO., INC. (JP) 2004-11-30 US disclosed
EP-1065200-A1 AMINOISOQUINOLINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2001-01-03 EP disclosed